Sage Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sage Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q3 2024.
  • Sage Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$101M, a 52.2% increase year-over-year.
  • Sage Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$372M, a 46.2% increase year-over-year.
  • Sage Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$580M, a 6.01% decline from 2022.
  • Sage Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$547M, a 18.7% decline from 2021.
  • Sage Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$461M, a 177% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$372M -$101M +$111M +52.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 -$483M -$111M +$59.2M +34.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 -$542M -$118M +$37.8M +24.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$580M -$42.1M +$112M +72.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 -$692M -$212M -$70.4M -49.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$621M -$170M -$42.1M -32.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 -$579M -$155M -$32.3M -26.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$547M -$154M -$28.4M -22.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 -$519M -$141M -$10.6M -8.09% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$508M -$128M -$20.4M -18.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$488M -$123M -$26.7M -27.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$461M -$125M -$1.1B -113% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $639M -$131M -$23.7M -22.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $662M -$108M +$30.9M +22.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $631M -$96.5M +$35.1M +26.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $596M $974M +$1.15B Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$552M -$107M +$80M +42.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$632M -$139M +$37.5M +21.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$670M -$132M +$38.2M +22.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$708M -$175M -$10.4M -6.34% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$698M -$187M -$58.4M -45.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 -$639M -$176M -$154M -697% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 -$485M -$170M -$91.7M -117% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$393M -$164M -$93.8M -133% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$299M -$129M -$54.4M -73.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$245M -$22.1M +$48.7M +68.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$294M -$78.1M -$20.6M -35.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$273M -$70.4M -$14.1M -25% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-19
Q3 2017 -$259M -$74.4M -$36.3M -95.4% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-19
Q2 2017 -$223M -$70.9M -$35.8M -102% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-19
Q1 2017 -$187M -$57.5M -$26.8M -87.1% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-19
Q4 2016 -$160M -$56.4M -$27.8M -97% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-22
Q3 2016 -$132M -$38.1M -$14M -58.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-22
Q2 2016 -$118M -$35M -$9.95M -39.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-22
Q1 2016 -$108M -$30.7M -$13.8M -81.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-22
Q4 2015 -$94.7M -$28.6M -$16.3M -131% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-24
Q3 2015 -$78.4M -$24.1M -$14.6M -154% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-24
Q2 2015 -$63.8M -$25.1M -$18.9M -305% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-24
Q1 2015 -$44.9M -$16.9M -$11.1M -192% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-24
Q4 2014 -$33.8M -$12.4M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$9.47M -$4.95M -110% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$6.19M -$1.53M -32.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$5.79M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q3 2013 -$4.52M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$4.66M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.